Loading
한화
한화플러스제4호기업인수목적 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest was filed 13 Sept 2023.
한화플러스제4호기업인수목적: what insiders have been doing
한화플러스제4호기업인수목적, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). In the past year (18 October 2025 to 18 October 2026), 1 filing came from 1 insider.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
There has been no open-market purchase by an insider of 한화플러스제4호기업인수목적 for at least a year.
With 1 filing in twelve months, the company is quieter than the median of 7 filings across the 2,648 companies we follow on the same exchange. Over the whole record (from 2023), the tally stands at 1 purchase and 4 sales.
For comparison within the same sector, see the insider buying recorded at Anixa Biosciences Inc and Vivos Inc. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
4 ops. · all time
Fundamental score
Ranked 459 of 24,148 companies
84.1
score / 100
Value100
Quality68
FCF yld·
Earn yld·
EV/EBITDA0.1x
ROE5.9%
Gross mgn40%
Net mgn11%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€0.02
Analyst consensus
Income statement
Revenue€1,696.4B
Gross profit€681.0B40% margin
EBITDA€260.1B15% margin
Net income€190.3B11.8% margin
Valuation
P/Book0.0x
Beta0.06
Balance sheet & cash
Market cap€45.0M
Total debt€16.8B
Free Cash Flow-€336.3B
Profitability & ownership
ROE5.9%
ROA4.3%
% insiders69.1%
% institutions11.5%
Last declaration on 11 March 2026
Declarations6 total
6 of 6 declarations
About 한화플러스제4호기업인수목적
Hanwha Plus No. 4 Special Purpose Acquisition Company is a special purpose acquisition company in the healthcare and pharmaceutical sector. It is listed on the XKRX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
